• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
PHA eludes macrophage suppression to activate CD8 T cells.PHA 逃避巨噬细胞抑制作用以激活 CD8 T 细胞。
Immunobiology. 2019 Jan;224(1):94-101. doi: 10.1016/j.imbio.2018.10.004. Epub 2018 Nov 3.
2
High macrophage PD-L1 expression not responsible for T cell suppression.高表达的巨噬细胞 PD-L1 并不负责 T 细胞抑制。
Cell Immunol. 2018 Feb;324:50-58. doi: 10.1016/j.cellimm.2017.12.013. Epub 2017 Dec 30.
3
Anti-PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment.抗 PD-L1 治疗导致巨噬细胞区室的功能重塑。
Cancer Res. 2019 Apr 1;79(7):1493-1506. doi: 10.1158/0008-5472.CAN-18-3208. Epub 2019 Jan 24.
4
Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.肿瘤细胞释放的自噬体(TRAPs)通过诱导 PD-L1 表达增加的 M2 样巨噬细胞促进免疫抑制。
J Immunother Cancer. 2018 Dec 18;6(1):151. doi: 10.1186/s40425-018-0452-5.
5
Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based Nanovaccine.舒尼替尼与 PD-L1 阻断联合增强 TLR7/8 激动剂纳米疫苗的抗癌疗效。
Mol Pharm. 2019 Mar 4;16(3):1200-1210. doi: 10.1021/acs.molpharmaceut.8b01165. Epub 2019 Jan 25.
6
Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.巨噬细胞上B7-H1的阻断通过增强干扰素-γ诱导的一氧化氮生成来抑制CD4+ T细胞增殖。
J Immunol. 2005 Aug 1;175(3):1586-92. doi: 10.4049/jimmunol.175.3.1586.
7
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.T 细胞与肿瘤微环境之间的 IFN-γ/PD-L1 轴:胶质母细胞瘤抗 PD-1/PD-L1 治疗的提示。
J Neuroinflammation. 2018 Oct 17;15(1):290. doi: 10.1186/s12974-018-1330-2.
8
Macrophage regulation of B cell proliferation.巨噬细胞对B细胞增殖的调节
Cell Immunol. 2017 Apr;314:54-62. doi: 10.1016/j.cellimm.2017.02.002. Epub 2017 Feb 21.
9
Differential expression of migration inhibitory and migration stimulatory factors in two lines of mice genetically selected for high or low responsiveness to phytohemagglutinin. 1. Migration stimulatory factor(s) from T and B cells of immune spleen.对植物血凝素高反应性或低反应性的两个品系小鼠中迁移抑制因子和迁移刺激因子的差异表达。1. 免疫脾中T细胞和B细胞的迁移刺激因子。
Exp Clin Immunogenet. 1991;8(3):140-58.
10
Spleen-derived IFN-γ induces generation of PD-L1-suppressive neutrophils during endotoxemia.脾脏来源的干扰素-γ在内毒素血症期间诱导产生PD-L1抑制性中性粒细胞。
J Leukoc Biol. 2017 Dec;102(6):1401-1409. doi: 10.1189/jlb.3A0217-051RR. Epub 2017 Oct 3.

引用本文的文献

1
Orchestration of Tumor-Associated Macrophages in the Tumor Cell-Macrophage-CD8 T Cell Loop for Cancer Immunotherapy.肿瘤细胞-巨噬细胞-CD8 T细胞循环中肿瘤相关巨噬细胞的调控用于癌症免疫治疗
Int J Biol Sci. 2025 Jun 12;21(9):4098-4116. doi: 10.7150/ijbs.115932. eCollection 2025.
2
Immunomodulatory Effects of Modified Bovine Colostrum, Whey, and Their Combination with Other Natural Products: Effects on Human Peripheral Blood Mononuclear Cells.改性牛初乳、乳清及其与其他天然产物组合的免疫调节作用:对人外周血单个核细胞的影响
Curr Ther Res Clin Exp. 2023 Oct 5;99:100720. doi: 10.1016/j.curtheres.2023.100720. eCollection 2023.
3
Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro.新型乙肝病毒多价疫苗中包含的野生型和G145R逃逸突变体的重组乙肝表面抗原(HBsAg),在体外对健康供体白细胞的影响上存在显著差异。
Vaccines (Basel). 2022 Feb 3;10(2):235. doi: 10.3390/vaccines10020235.
4
IgD ligation allows peritoneal cavity B cell proliferation.IgD 交联可导致腹腔 B 细胞增殖。
Immunobiology. 2022 Mar;227(2):152181. doi: 10.1016/j.imbio.2022.152181. Epub 2022 Jan 20.
5
Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells.靶向胆管癌细胞上表达的整合素αvβ6的嵌合抗原受体T细胞
Front Oncol. 2021 Mar 3;11:657868. doi: 10.3389/fonc.2021.657868. eCollection 2021.
6
Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma.用于胆管癌过继性T细胞治疗的抗粘蛋白1嵌合抗原受体T细胞
Sci Rep. 2021 Mar 18;11(1):6276. doi: 10.1038/s41598-021-85747-9.

本文引用的文献

1
T Cell Dysfunction in Cancer.肿瘤中的 T 细胞功能障碍。
Cancer Cell. 2018 Apr 9;33(4):547-562. doi: 10.1016/j.ccell.2018.03.012.
2
Next generation of immune checkpoint therapy in cancer: new developments and challenges.癌症免疫检查点治疗的新一代:新进展与新挑战。
J Hematol Oncol. 2018 Mar 15;11(1):39. doi: 10.1186/s13045-018-0582-8.
3
The tumour glyco-code as a novel immune checkpoint for immunotherapy.肿瘤糖码作为免疫治疗的新型免疫检查点。
Nat Rev Immunol. 2018 Mar;18(3):204-211. doi: 10.1038/nri.2018.3. Epub 2018 Feb 5.
4
Perspectives on Systems Modeling of Human Peripheral Blood Mononuclear Cells.人类外周血单个核细胞的系统建模观点
Front Mol Biosci. 2018 Jan 9;4:96. doi: 10.3389/fmolb.2017.00096. eCollection 2017.
5
Targeting and Recognition of Toll-Like Receptors by Plant and Pathogen Lectins.植物和病原体凝集素对Toll样受体的靶向作用与识别
Front Immunol. 2017 Dec 18;8:1820. doi: 10.3389/fimmu.2017.01820. eCollection 2017.
6
High macrophage PD-L1 expression not responsible for T cell suppression.高表达的巨噬细胞 PD-L1 并不负责 T 细胞抑制。
Cell Immunol. 2018 Feb;324:50-58. doi: 10.1016/j.cellimm.2017.12.013. Epub 2017 Dec 30.
7
Mechanisms regulating T-cell infiltration and activity in solid tumors.调控实体瘤中 T 细胞浸润和活性的机制。
Ann Oncol. 2017 Dec 1;28(suppl_12):xii18-xii32. doi: 10.1093/annonc/mdx238.
8
Novel "Elements" of Immune Suppression within the Tumor Microenvironment.肿瘤微环境中的免疫抑制新“元素”。
Cancer Immunol Res. 2017 Jun;5(6):426-433. doi: 10.1158/2326-6066.CIR-17-0117.
9
Role of tumor microenvironment in tumorigenesis.肿瘤微环境在肿瘤发生中的作用。
J Cancer. 2017 Feb 25;8(5):761-773. doi: 10.7150/jca.17648. eCollection 2017.
10
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment.肿瘤微环境中肿瘤细胞与免疫细胞的代谢特征
Front Immunol. 2017 Mar 8;8:248. doi: 10.3389/fimmu.2017.00248. eCollection 2017.

PHA 逃避巨噬细胞抑制作用以激活 CD8 T 细胞。

PHA eludes macrophage suppression to activate CD8 T cells.

机构信息

Biology Department, Rider University, Lawrenceville, New Jersey, United States.

Biology Department, Rider University, Lawrenceville, New Jersey, United States.

出版信息

Immunobiology. 2019 Jan;224(1):94-101. doi: 10.1016/j.imbio.2018.10.004. Epub 2018 Nov 3.

DOI:10.1016/j.imbio.2018.10.004
PMID:30446337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6387856/
Abstract

Tumors may include a high proportion of immune modulatory cells and molecules that restrain the anti-cancer response. Activation of T cells to eliminate cancer cells within the immune-suppressive tumor microenvironment remains a challenge. We have shown that C57BL/6 J peritoneal cell culture models features of macrophage-dense tumors as TCR ligation fails to activate T cells unless IFNγ is neutralized or iNOS is inhibited. We tested other forms of T cell activation and found phytohemagglutinin (PHA) distinctive in the ability to markedly expand CD8 T cells in this model. IFNγ or iNOS inhibition was not necessary for this response. PHA triggered less IFNγ production and inhibitory PD-L1 expression than TCR ligation. Macrophages and CD44 T cells bound PHA. Spleen T cell responses to PHA were markedly enhanced by the addition of peritoneal cells revealing that macrophages enhance T cell expansion. That PHA increases CD8 T cell responses within macrophage-dense culture suggests this mitogen might enhance anti-tumor immunity.

摘要

肿瘤可能包含大量免疫调节细胞和分子,这些细胞和分子抑制了抗癌反应。在免疫抑制性肿瘤微环境中激活 T 细胞以消除癌细胞仍然是一个挑战。我们已经表明,C57BL/6J 腹膜细胞培养模型具有巨噬细胞密集型肿瘤的特征,因为 TCR 交联不能激活 T 细胞,除非中和 IFNγ 或抑制 iNOS。我们测试了其他形式的 T 细胞激活,发现植物血凝素 (PHA) 在这种模型中具有显著扩增 CD8 T 细胞的能力。这种反应不需要 IFNγ 或 iNOS 抑制。PHA 引发的 IFNγ 产生和抑制性 PD-L1 表达少于 TCR 交联。PHA 与巨噬细胞和 CD44 T 细胞结合。添加腹膜细胞可显著增强脾 T 细胞对 PHA 的反应,表明巨噬细胞增强了 T 细胞的扩增。PHA 增加巨噬细胞密集培养物中 CD8 T 细胞反应表明,这种有丝分裂原可能增强抗肿瘤免疫。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/60ae197c5729/nihms-1512612-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/f87de16f4bb2/nihms-1512612-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/513c8d37db1c/nihms-1512612-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/2d5fbb106906/nihms-1512612-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/357411e1974e/nihms-1512612-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/af3ec51a3116/nihms-1512612-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/3bb1a17f9eec/nihms-1512612-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/7c8099ad9b54/nihms-1512612-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/197a4425ad09/nihms-1512612-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/3a7c45908ca7/nihms-1512612-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/60ae197c5729/nihms-1512612-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/f87de16f4bb2/nihms-1512612-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/513c8d37db1c/nihms-1512612-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/2d5fbb106906/nihms-1512612-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/357411e1974e/nihms-1512612-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/af3ec51a3116/nihms-1512612-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/3bb1a17f9eec/nihms-1512612-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/7c8099ad9b54/nihms-1512612-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/197a4425ad09/nihms-1512612-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/3a7c45908ca7/nihms-1512612-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651e/6387856/60ae197c5729/nihms-1512612-f0010.jpg